Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: Roles in regulation of cardiovascular function

被引:56
作者
Ralevic, V [1 ]
Kendall, DA
Randall, MD
Smart, D
机构
[1] Univ Nottingham, Sch Med, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England
[2] GlaxoSmithKline, Neurol CEDD, Harlow CM19 5AW, Essex, England
关键词
anandamide; cannabinoids; sensory nerves; vanilloids; vasorelaxation;
D O I
10.1016/S0024-3205(02)02086-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Capsaicin-sensitive sensory nerves are widely distributed in the cardiovascular system. They are activated by a variety of physical and chemical stimuli, characteristically by capsaicin acting via the vanilloid receptor VR1, and have a role in the regulation of peripheral vascular resistance and maintenance of homeostasis via their afferent and efferent functions. Cannabinoids, a recently discovered family of extracellular signalling molecules, can act at cannabinoid (CB) receptors expressed on sensory nerves, to cause inhibition of sensory neurotransmitter release. There is recent evidence, however, that anandamide, an endogenous cannabinoid, can activate VR1, coexpressed. with CB receptors on the same sensory nerve terminals, causing a release of sensory neurotransmitter, vasorelaxation and hypotension. Hence, anandamide can elicit opposite actions, inhibition via CB receptors and excitation via VR1, on sensory neurotransmission. The possible biological significance of this is discussed. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:2577 / 2594
页数:18
相关论文
共 114 条
[1]   Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons [J].
Ahluwalia, J ;
Urban, L ;
Capogna, M ;
Bevan, S ;
Nagy, I .
NEUROSCIENCE, 2000, 100 (04) :685-688
[2]   The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice [J].
Al-Hayani, A ;
Wease, KN ;
Ross, RA ;
Pertwee, RG ;
Davies, SN .
NEUROPHARMACOLOGY, 2001, 41 (08) :1000-1005
[3]  
BARJA F, 1983, CELL TISSUE RES, V229, P411
[4]   Anandamide transport inhibition by the varmilloid agonist olvanil [J].
Beltramo, M ;
Piomelli, D .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 364 (01) :75-78
[5]   Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide [J].
Bisogno, T ;
Hanus, L ;
De Petrocellis, L ;
Tchilibon, S ;
Ponde, DE ;
Brandi, I ;
Moriello, AS ;
Davis, JB ;
Mechoulam, R ;
Di Marzo, V .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (04) :845-852
[6]  
Bonhaus DW, 1998, J PHARMACOL EXP THER, V287, P884
[7]   A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1 - Evidence for a new model of receptor/ligand interactions [J].
Bouaboula, M ;
Perrachon, S ;
Milligan, L ;
Canat, X ;
RinaldiCarmona, M ;
Portier, M ;
Barth, F ;
Calandra, B ;
Pecceu, F ;
Lupker, J ;
Maffrand, JP ;
LeFur, G ;
Casellas, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) :22330-22339
[8]   CB1 receptor antagonist SR141716A inhibits Ca2+-induced relaxation in CB1 receptor-deficient mice [J].
Bukoski, RD ;
Bátkai, S ;
Járai, Z ;
Wang, YL ;
Offertaler, L ;
Jackson, WF ;
Kunos, G .
HYPERTENSION, 2002, 39 (02) :251-257
[9]   The vanilloid receptor: A molecular gateway to the pain pathway [J].
Caterina, MJ ;
Julius, D .
ANNUAL REVIEW OF NEUROSCIENCE, 2001, 24 :487-517
[10]   Impaired nociception and pain sensation in mice lacking the capsaicin receptor [J].
Caterina, MJ ;
Leffler, A ;
Malmberg, AB ;
Martin, WJ ;
Trafton, J ;
Petersen-Zeitz, KR ;
Koltzenburg, M ;
Basbaum, AI ;
Julius, D .
SCIENCE, 2000, 288 (5464) :306-313